Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
(Re-correction) "Appendix to the Consolidated Financial Summary Fiscal 2025"
(Corrections / Corrections of Numerical Data) Consolidated Financial Summary (IFRS) Fiscal 2025
Notice Regarding the Discontinuation of Rocatinlimab Clinical Trials
(Correction) "Appendix to the Consolidated Financial Summary Fiscal 2025"
Announcement regarding the Partial amendments to the Articles of Incorporation
Consolidated Financial Summary (IFRS) Fiscal 2025
Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2025
Announcement Regarding Change in Dividend Policy (DOE and Progressive Dividends)
Kyowa Kirin, Last Fiscal Year's Net Income Unexpectedly Increases, 12% Increase in The Current Fiscal Year, Increased Previous Year's Dividend by 2 Yen, This Fiscal Year to Increase Dividend by 8 Yen
Notice Regarding Kyowa Kirin Regaining Control of Rocatinlimab Development and Commercialization Program
Notice Regarding Change in Management Structure (CEO Succession)
Announcement regarding the Transition to Company with Audit and Supervisory Committee
Appendix to the Consolidated Financial Summary Fiscal 2025 Third Quarter
Consolidated Financial Summary Fiscal 2025 Third Quarter
Kyowa Kirin, Jan-Sep (Cumulative 3Q) Net Income Decreases by 42%, Jul-Sep Net Income Decreases by 10%
CORPORATE GOVERNANCE REPORT
Kyowa Kirin, First Half Net Income Decreases by 57%, Apr-Jun Net Income Decreases by 56%
Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2025 Semi Annual
Consolidated Financial Summary (IFRS) Fiscal 2025 Semi Annual
Corporate Governance Report